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Adequate hemodynamic management using well-deﬁ  ned 
perioperative goal-directed therapy (GDT) is a corner-
stone of tissue perfusion and oxygenation that can 
improve outcome. Th  e aim of GDT is to prevent tissue 
oxygen debt and energy crisis by maintaining adequate 
tissue perfusion and oxygenation in relation to increased 
metabolic demand during major surgery.
In an elegant study in the previous issue of Critical 
Care, Jhanji and colleagues [1] highlighted the important 
pathophysiological mechanisms involved behind the 
beneﬁ  t of GDT. Th   e authors showed that stroke volume-
targeted colloid administration coupled with a ﬁ  xed 
infusion rate of dopexamine improved oxygen delivery 
(DO2), central venous oxygen saturation (ScvO2), micro-
vascular blood ﬂ  ow, and tissue oxygenation and that ﬂ  uid 
therapy alone led to additional modest improvements. 
Th  ese data echo previous ﬁ  ndings that optimizing DO2
improves outcome [2-5] and that microvascular ﬂ  ow 
abnormalities could be a key point in determining 
postoperative complications following high-risk surgery 
[6]. Th   ese results were consistent with those of Lobo and 
colleagues [5], who compared the use of ﬂ  uids and dobu-
tamine and ﬂ  uids alone in high-risk surgical patients. Th  e 
use of ﬂ  uids and dobutamine to achieve a DO2 goal (of 
greater than 600  mL/min per m2) determined better 
postoperative outcomes than ﬂ  uids alone did.
Th  e study of Jhanji and colleagues, however, raises 
several important questions that might deserve future 
clinical trials. First, we have to ask whether the hemo-
dynamic optimization should be performed postopera-
tively or, more logically, once the surgical trauma is 
induced. In the three study groups, it is clear that baseline 
postoperative inﬂ   ammatory markers were largely 
elevated, rendering the hemodynamic optimiza  tion less 
able to reduce complications that appear to be present at 
a very high rate regardless of the intervention protocol 
(between 58% and 69% of the patients). Indeed, several 
pieces of evidence suggest that the timing of therapeutic 
intervention during GDT could be a critical issue [7], and 
most studies predominantly performed GDT starting 
intraoperatively [8]. Second, one may question the use of 
a ﬁ  xed low infusion rate of dopexa  mine (0.5 μg/kg per 
minute) without targeting any speciﬁ  c goals for cardiac 
output or DO2. Although the use of a low dose of 
dopexamine demonstrated beneﬁ  ts in terms of survival 
and reduction in hospital stay in a previous small-scale 
study [9], this was not observed here by Jhanji and 
colleagues [1] in this randomized trial on a larger scale. 
In the latter context, it seems important to emphasize 
that the serum lactate concentration and the base deﬁ  cit 
remained a bit higher (though not signiﬁ  cantly so) during 
the ﬁ   rst 4 hours of treatment in the ﬁ  xed-dose 
dopexamine treatment group. Th  erefore, two important 
complementary questions remain: Do we need, as for 
ﬂ   uids, an individualized approach to deliver inotrope 
during GDT? What should be the goal to address the 
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perspective, it is certainly much more important to 
consider the DO2-to-O2 consumption (VO2) relationship 
than to indicate a speciﬁ  c value of DO2 as a goal [10]. To 
this end, Donati and colleagues [7] demonstrated 
improved outcome in patients treated with individualized 
GDT using ﬂ  uids and dobutamine titrated to maintain O2 
extraction (ERO2, the ratio of VO2 to DO2) at less than 
27% (corresponding approximately to an ScvO2 of greater 
than 73%). An increase in VO2 without a corresponding 
increase in DO2, or a decrease in DO2 and no change in 
O2 requirements, results in an increase in ERO2, 
rendering ScvO2 an interesting contributor to patient 
monitoring. In critical illness, however, the ability of 
tissue to increase ERO2 might be impaired, and 
‘normalized ScvO2’ would lose its ability to guide ﬂ  uid or 
inotrope therapy [11,12]. Th  is constitutes the third 
impor  tant remaining issue raised by this study: Should 
we systematically integrate other markers of cellular 
energy adequacy (besides ScvO2) such as serum lactate 
[12,13], base deﬁ  cit, or tissue hypercarbia [14]? In any 
case, these markers deserve further investigations in 
GDT-based protocols, as has been done in critical illness 
such as severe sepsis [12,15], before being considered 
eligible tools for high-risk surgery.
In total, we believe it would be more rational to apply 
GDT according to individual patients’ targets based on 
their speciﬁ  c physiological proﬁ  le, whether it pertains to 
ﬂ  uid loading or dopexamine titration. It is obvious that 
the use of inotropes should be cautious in patients with 
high risk of ischemic cardiovascular events, in which beta 
stimulation may be harmful. In a previous study of 122 
high-risk patients (81% with an American Society of 
Anesthesiologists score of at least 3), Pearse and colleagues 
[16] reported a 13% rate of adverse events (tachycardia 
and myocardial ischemia) using mean doses of dopexa-
mine of 0.75 μg/kg per minute (interquartile range of 0.5 
to 1.0 μg/kg per minute) whereas 24% of patients did not 
achieve the DO2 goal despite receiving the maximum 
therapy allowed. Inotrope titration should integrate the 
relationship of O2 needs to the O2 costs to be delivered. 
Finally, we feel that GDT must be applied at the time of 
injury (that is, intraoperatively) and not after inﬂ  amma-
tion has already started. Such an approach, applied in 
further clinical trials, might provide us with responses to 
our yet unanswered questions.
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